Related Experiment Video
Updated: Apr 18, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus
Hejun Li1, Shunping Lin, Shangchih Yang
1Department of Rheumatology, Union Hospital, Fujian Medical University, 29 Xinquan Road, Fuzhou, 350001, China, tanklhj@163.com.
Insights
Low serum C3 and C4 complement levels, particularly when low simultaneously, significantly improve the diagnosis of systemic lupus erythematosus (SLE). Testing both C3 and C4 together enhances diagnostic sensitivity for SLE.
Area of Science:
- Immunology
- Rheumatology
- Clinical Diagnostics
Background:
- Hypocomplementemia involving C3, C4, and CH50 was proposed in 2009 as an immunologic criterion to improve systemic lupus erythematosus (SLE) classification sensitivity.
- The diagnostic utility of low serum complement C3 and C4 levels in Chinese SLE patients requires further evaluation.
Purpose of the Study:
- To assess the diagnostic value of low serum complement C3 and C4 levels in Chinese patients diagnosed with SLE.
- To determine optimal cut-off values for C3 and C4 for SLE diagnosis.
- To evaluate the impact of including hypocomplementemia in SLE classification criteria.
Main Methods:
- Retrospective analysis of 2452 patients (158 with SLE, 2294 with other diseases).
- Receiver operating characteristic (ROC) analysis to determine optimal C3 and C4 cut-off levels.
- Prevalence assessment of low C3/C4 levels alone and simultaneously in SLE and non-SLE groups.
- Evaluation of antinuclear antibody (ANA) sensitivity and likelihood ratios.
Main Results:
- Optimal C3 cut-off: 0.785 g/L (sensitivity 77.9%, specificity 81.5%).
- Optimal C4 cut-off: 0.145 g/L (sensitivity 80.1%, specificity 83.2%).
- Simultaneously low C3 and C4 levels were significantly more prevalent in SLE patients (73.42%) compared to other diseases.
- Inclusion of hypocomplementemia increased SLE classification by 16.18%.
- High prevalence of hypocomplementemia (41.94%) observed in patients with hematological disease.
Conclusions:
- Simultaneously low C3 and C4 levels are valuable diagnostic indicators for SLE, significantly enhancing diagnostic sensitivity.
- Low C3 or C4 levels alone are insufficient as immunological criteria for SLE diagnosis; simultaneous testing is crucial.
- Hypocomplementemia improves SLE classification sensitivity and holds diagnostic importance.
Abstract:
In 2009, hypocomplementemia involving C3, C4, and total hemolytic complement (CH50) was proposed as an immunologic criterion to enhance the sensitivity of systemic lupus erythematosus (SLE) classification criteria. This study evaluated the diagnostic value of low serum complement C3 and C4 levels in Chinese patients with SLE. In total, 2452 patients were enrolled in this study (158 with SLE and 2294 with other diseases). Receiver operating characteristic analysis showed that the optimal C3 and C4 cut-off levels for a diagnosis of SLE were 0.785 g/L (sensitivity, 77.9%; specificity, 81.5%) and 0.145 g/L (sensitivity, 80.1%; specificity, 83.2%), respectively. The prevalence of a low C3 or C4 level alone was similar between patients with SLE and those with other diseases, while the prevalence of simultaneously low C3 and C4 levels was higher in patients with SLE (73.42%). Antinuclear antibody had a high sensitivity (96.64%) and low negative likelihood ratio (0.04). Hypocomplementemia with positive antinuclear antibody had a high positive likelihood ratio. Inclusion of hypocomplementemia as a classification criterion for SLE resulted in a 16.18% increase in the number of patients assigned to the SLE group (from 136 to 158 patients). Hypocomplementemia was highly prevalent in patients with hematological disease (41.94%). These results suggest that hypocomplementemia has important diagnostic value for SLE by improving the sensitivity of the diagnosis of SLE. C3 and C4 should be tested simultaneously because a low C3 or C4 level alone is not a suitable immunological criterion.
Related Concept Videos
Complement System
Serum Studies: Renal Function Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

